Source:http://linkedlifedata.com/resource/pubmed/id/17318300
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2007-2-23
|
pubmed:abstractText |
Dyslipidemia and insulin resistance contribute to the endothelial cell dysfunction in hypertensive disorders of pregnancy (HDP) and increase the long-term risk of cardiovascular disease (CVD). The genes linking susceptibility to gestational hypertension (GH) and/or preeclampsia (PE) to the long-term risk of CVD are still unknown. We evaluated the potential association between 14 polymorphisms from six genes involved in lipid metabolism and insulin action and the risk of HDP: namely the lipoprotein lipase (LPL), hepatic lipase (LIPC), hormone sensitive lipase (LIPE), cholesteryl ester transfer protein (CETP), ApoCIII and ApoE gene polymorphisms. Overall, 169 women with HDP [proteinuria (PE) and gestational hypertension without proteinuria (GH)] and 169 controls matched for age and year of delivery were genotyped. Homozygosity of the -514T allele of the -514C > T polymorphism (LIPC gene) decreased the risk of GH (OR = 0.17, CI(95): 0.02-0.76), while there were more -60G carriers of the -60C > G LIPE gene polymorphism (OR = 3.51, CI(95):1.02-12.10) among GH cases, but not in PE cases. The common ApoCIII two-locus -482CC/3238CC genotype was lower in women with GH compared with controls (OR = 0.53, CI(95): 0.3-0.9). The combined frequency of at-risk genotypes was higher in cases of GH compared with controls [one at-risk genotype: OR = 3.38 (95% CI: 0.48-41.8); two or more at-risk genotypes: OR = 7.14 (95% CI: 1.21-92.3, P = 0.01)], suggesting a gene-dose effect. We conclude that the combined effect of LIPC, LIPE and ApoCIII gene polymorphisms may increase the likelihood of GH, but seemingly not of PE.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Apolipoprotein C-III,
http://linkedlifedata.com/resource/pubmed/chemical/Apolipoproteins E,
http://linkedlifedata.com/resource/pubmed/chemical/Lipase,
http://linkedlifedata.com/resource/pubmed/chemical/Sterol Esterase,
http://linkedlifedata.com/resource/pubmed/chemical/hepatic lipase, human
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1434-5161
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
52
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
244-54
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:17318300-Adult,
pubmed-meshheading:17318300-Apolipoprotein C-III,
pubmed-meshheading:17318300-Apolipoproteins E,
pubmed-meshheading:17318300-Case-Control Studies,
pubmed-meshheading:17318300-Female,
pubmed-meshheading:17318300-Genetic Predisposition to Disease,
pubmed-meshheading:17318300-Humans,
pubmed-meshheading:17318300-Hypertension, Pregnancy-Induced,
pubmed-meshheading:17318300-Linkage Disequilibrium,
pubmed-meshheading:17318300-Lipase,
pubmed-meshheading:17318300-Polymorphism, Genetic,
pubmed-meshheading:17318300-Pre-Eclampsia,
pubmed-meshheading:17318300-Pregnancy,
pubmed-meshheading:17318300-Risk Factors,
pubmed-meshheading:17318300-Sterol Esterase
|
pubmed:year |
2007
|
pubmed:articleTitle |
The combination of ApoCIII, hepatic lipase and hormono sensitive lipase gene polymorphisms suggests an association with susceptibility to gestational hypertension.
|
pubmed:affiliation |
Unité de Recherche en Périnatalogie, Centre de Recherche du CHUQ, Hôpital Saint-François d'Assise, 10, rue de l'Espinay, G1L 3L5 Quebec, QC, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|